Marsha E Reichman

Years Active: 2017-2018
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, Jennifer Nelson, Sengwee Toh, Azadeh Shoaibi, Marsha E Reichman, Shirley Wang, Michael Nguyen, Rongmei Zhang, Rima Izem, Margie R Goulding, Mary Ross Southworth, David J Graham, Candace Fuller, Hannah Katcoff, Tiffany Woodworth, Catherine Rogers, Ryan Saliga, Nancy D Lin, Cheryl N McMahill-Walraven, Vinit P Nair, Kevin Haynes, Ryan M Carnahan
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. Pharmacoepidemiology and drug safety 27 (3) (2018)
Joshua J Gagne, Monika Houstoun, Marsha E Reichman, Christian Hampp, James H Marshall, Sengwee Toh
Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system. Pharmacoepidemiology and drug safety 27 (1) (2017)
Marsha E Reichman, Michael Wernecke, David J Graham, Jiemin Liao, John Yap, Yoganand Chillarige, Mary Ross Southworth, Stephine Keeton, Margie R Goulding, Katrina Mott, Jeffrey A Kelman
Antihypertensive drug associated angioedema: effect modification by race/ethnicity. Pharmacoepidemiology and drug safety 26 (10) (2017)

Marsha E Reichman.css-eqlu8i{font-size:small;padding-left:4px;}